Cite
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies
MLA
Laura Blockley, et al. “A Retrospective Analysis of RET Translocation, Gene Copy Number Gain and Expression in NSCLC Patients Treated with Vandetanib in Four Randomized Phase III Studies.” BMC Cancer, vol. 15, no. 1. EBSCOhost, https://doi.org/10.1186/s12885-015-1146-8. Accessed 15 Feb. 2025.
APA
Laura Blockley, Richard De Boer, Jessica Read, Neil Gray, Graham Bigley, James Vasselli, Qunsheng Ji, Jin Soo Lee, Angela Dale, J. Stevens, Carl John Cresswell, Victoria Williams, John Edward Norris Morten, Haihua Fu, Paul Elvin, Shuqiong Fan, Amanda Gladwin, Tianwei Zhang, Emma Donald, … Adam Platt. (n.d.). A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies. BMC Cancer, 15(1). https://doi.org/10.1186/s12885-015-1146-8
Chicago
Laura Blockley, Richard De Boer, Jessica Read, Neil Gray, Graham Bigley, James Vasselli, Qunsheng Ji, et al. 2025. “A Retrospective Analysis of RET Translocation, Gene Copy Number Gain and Expression in NSCLC Patients Treated with Vandetanib in Four Randomized Phase III Studies.” BMC Cancer 15 (1). Accessed February 15. doi:10.1186/s12885-015-1146-8.